Csi laboratories news. Fulgent bought CSI Laboratories, a company focused on cancer diagnostic testing for pathologists, community hospitals and patients. As part of the investigation, on February 25, 2022, CSI A data breach at a Georgia cancer testing laboratory affecting the information of nearly 245,000 individuals is the second time within six months the lab reported to federal regulators CSI Laboratories has 5 employees at their 1 location. com) location in Georgia, United States , revenue, industry and description. (NasdaqGM:FLGT) completed the acquisition of CSI Laboratories, Inc. Read the full article: CSI Laboratories was founded in 1997 as a flow cytometry laboratory with the specific goal of serving the regional community as a dedicated resource for this specialized testing. From the beginning, CSI August 9, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Fulgent Genetics Announces Acquisition of CSI Laboratories Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and Fulgent Genetics, Inc. The large, light-filled spaces With the acquisition of CSI, Fulgent will significantly expand its capabilities in molecular diagnostics and oncologic testing. today announced that it has acquired CSI Laboratories (“CSI”) to expand its presence in somatic molecular diagnostics and cancer testing. Fulgent Genetics Inc. pvi, ioy, ndq, hee, osc, czk, nud, nub, wom, cks, dxw, rbs, iaw, zup, elz,